Autolus Therapeutics (AUTL) Earnings Date, Estimates & Call Transcripts

$4.39
+0.32 (+7.86%)
(As of 05/17/2024 08:53 PM ET)

Earnings Summary

Upcoming
Earnings Date
Aug. 1Estimated
Actual EPS
(Mar. 14)
-$0.44 Missed By -$0.18
Consensus EPS
(Mar. 14)
-$0.26
Skip Charts & View Estimated and Actual Earnings Data

AUTL Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

AUTL Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Autolus Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241($0.30)($0.30)($0.30)
Q2 20241($0.29)($0.29)($0.29)
Q3 20241($0.28)($0.28)($0.28)
Q4 20241($0.26)($0.26)($0.26)
FY 20244($1.13)($1.13)($1.13)

AUTL Earnings Date and Information

Autolus Therapeutics last issued its quarterly earnings results on March 14th, 2024. The reported ($0.44) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.26) by $0.18. Autolus Therapeutics has generated ($1.20) earnings per share over the last year (($1.20) diluted earnings per share). Earnings for Autolus Therapeutics are expected to grow in the coming year, from ($0.71) to ($0.57) per share. Autolus Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off prior year's report dates.

Autolus Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/1/2024
Estimated)
------- 
3/14/2024Q4 2023($0.26)($0.44)($0.18)($0.44)--
11/2/2023Q3 2023($0.24)($0.26)($0.02)($0.26)$2.00 million$0.41 million
8/3/2023Q2 2023($0.22)($0.26)($0.04)($0.26)--
5/4/2023Q1 2023($0.28)($0.23)+$0.05($0.23)$1.09 million$1.29 million
3/7/2023Q4 2022($0.31)($0.23)+$0.08($0.23)$4.50 million$3.83 million
11/3/2022Q3 2022($0.46)($0.47)($0.01)($0.47)$0.30 million$2.37 million
8/4/2022Q2 2022($0.42)($0.46)($0.04)($0.46)--    
5/5/2022Q1 2022($0.51)($0.41)+$0.10($0.41)$0.26 million$0.17 million    
3/10/2022Q4 2021($0.49)($0.51)($0.02)($0.51)$0.27 million$0.18 million    
11/2/2021Q3 2021($0.51)($0.47)+$0.04($0.47)$0.25 million$0.24 million    
8/5/2021Q2 2021($0.50)($0.47)+$0.03($0.47)$0.31 million$1.65 million    

Autolus Therapeutics Earnings - Frequently Asked Questions

When is Autolus Therapeutics's earnings date?

Autolus Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off last year's report dates. Learn more on AUTL's earnings history.

Did Autolus Therapeutics beat their earnings estimates last quarter?

In the previous quarter, Autolus Therapeutics (NASDAQ:AUTL) missed the analysts' consensus estimate of ($0.26) by $0.18 with a reported earnings per share (EPS) of ($0.44). Learn more on analysts' earnings estimate vs. AUTL's actual earnings.

How much revenue does Autolus Therapeutics generate each year?

Autolus Therapeutics (NASDAQ:AUTL) has a recorded annual revenue of $1.70 million.

How much profit does Autolus Therapeutics generate each year?

Autolus Therapeutics (NASDAQ:AUTL) has a recorded net income of -$208.38 million. AUTL has generated -$1.20 earnings per share over the last four quarters.

What is Autolus Therapeutics's EPS forecast for next year?

Autolus Therapeutics's earnings are expected to grow from ($0.71) per share to ($0.57) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:AUTL) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners